Li Chao, Li Hang, Wen Yu-Bing, Li Jia-Ning, Lin Wei-Feng, Cai Jian-Fang, Duan Lin, Li Yan, Li Xue-Mei, Li Xue-Wang
Department of Nephrology,PUMC Hospital, CAMS and PUMC,Beijing 100730,China.
Department of Internal Medicine,PUMC Hospital, CAMS and PUMC,Beijing 100730,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):544-551. doi: 10.3881/j.issn.1000-503X.2017.04.014.
Objective To investigate the clinicopathological features and prognosis of idiopathic membranous nephropathy(IMN)in adolescents. Methods This was a retrospective study on IMN patients hospitalized between June 2012 and December 2014,and a total of 33 IMN patients aged between 13 and 24 years old were enrolled in the study.Meanwhile,33 IMN patients aged more than 24 years old were selected randomly as control group during the same period.Diagnosis was confirmed by renal biopsy,and the secondary causes of membranous nephropathy were ruled out.Data collected from medical record and biopsy were analyzed. Results In the adolescent IMN group,the mean age at renal biopsy was(20±3)years old,and the male/female ratio was 22/11.Twenty-three cases presented as nephrotic syndrome.Systolic and diastolic pressures were(127±13)mmHg and(77±9)mmHg,respectively.The median 24-hour urine protein was 5.14(3.39,9.31)g/d,and the median serum creatinine was 62(52,73)μmol/L.The positive rate of serum anti-phospholipase A2 receptor in adolescent group was 54%.Compared with control group,the adolescent patients had lower incidence of hypertension and higher baseline estimated glomerular filtration rate level [15.2% vs.39.3%,χ=4.889,P=0.03;125 ml/(min·1.73m)vs.100 ml/(min·1.73m),U=137.5,P<0.001].According to IMN staging criteria in electron microscopy,adolescent patients were classified as one case in stage I,21 in stage Ⅱ,and 11 in stage Ⅲ or higher.The positive rates of IgG1,IgG2,IgG3 and IgG4 subclass staining in glomeruli were 46.9%,3.1%,56.3%,and 87.5%,respectively.Compared with control group,the adolescent patients had lower incidence of renal interstitial fibrosis and arteriolar lesions(6.1% vs.66.7%,χ=26.19,P<0.001;15.2% vs.66.7%,χ=18.11,P<0.001).Three patients lost to follow-up while others started steroid combined with cyclosporine A(n=20),cyclophosphamide(n=7),or mycophenolate(n=1)or solely(n=2).After a median follow-up of 18(12,24)months,the median proteinuria decreased to 0.20(0.10,0.42)g/d,whereas serum creatinine level remained stable [69(56.8,81.3)μmol/L].Seventeen patients(56.7%)achieved complete remission(CR),and the remaining 13 patients(43.4%)achieved partial remission(PR).The median time of CR and PR were three and six months,respectively.Only one patient relapsed during the follow-up.Also,21 cases received maintenance therapy including cyclosporine A(n=18),azathioprine(n=2)and mycophenolate(n=1).Conclusions The immunofluorescence IgG subclass in glomeruli and distribution of serum anti-phospholipase A2 receptor in adolescent IMN patients are similar to those in older IMN patients.IMN patients in adolescents responded well to immunosuppressive therapy.Cyclosporine A in low dose as maintenance therapy is effective after achieving remission,and will not increase risk of nephrotoxicity.
探讨青少年特发性膜性肾病(IMN)的临床病理特征及预后。方法:本研究为回顾性研究,纳入2012年6月至2014年12月期间住院的IMN患者,共纳入33例年龄在13至24岁之间的IMN患者。同时,同期随机选取33例年龄大于24岁的IMN患者作为对照组。通过肾活检确诊,并排除膜性肾病的继发性病因。分析病历和活检收集的数据。结果:青少年IMN组肾活检时的平均年龄为(20±3)岁,男女比例为22/11。23例表现为肾病综合征。收缩压和舒张压分别为(127±13)mmHg和(77±9)mmHg。24小时尿蛋白中位数为5.14(3.39,9.31)g/d,血清肌酐中位数为62(52,73)μmol/L。青少年组血清抗磷脂酶A2受体阳性率为54%。与对照组相比,青少年患者高血压发病率较低,基线估计肾小球滤过率水平较高[15.2%对39.3%,χ=4.889,P=0.03;125 ml/(min·1.73m²)对100 ml/(min·1.73m²),U=137.5,P<0.001]。根据电子显微镜下的IMN分期标准,青少年患者中I期1例,Ⅱ期21例,Ⅲ期及以上11例。肾小球中IgG1、IgG2、IgG3和IgG4亚类染色阳性率分别为46.9%、3.1%、56.3%和87.5%。与对照组相比,青少年患者肾间质纤维化和小动脉病变的发生率较低(6.1%对66.7%,χ=26.19,P<0.001;15.2%对66.7%,χ=18.11,P<0.001)。3例失访,其余患者开始使用激素联合环孢素A(n=20)、环磷酰胺(n=7)、霉酚酸酯(n=1)或单独使用(n=2)治疗。中位随访18(12,24)个月后,蛋白尿中位数降至0.20(0.10,0.42)g/d,而血清肌酐水平保持稳定[69(56.8,81.3)μmol/L]。17例患者(56.7%)达到完全缓解(CR),其余13例患者(43.4%)达到部分缓解(PR)。CR和PR的中位时间分别为3个月和6个月。随访期间仅1例患者复发。此外,21例患者接受维持治疗,包括环孢素A(n=18)、硫唑嘌呤(n=2)和霉酚酸酯(n=1)。结论:青少年IMN患者肾小球免疫荧光IgG亚类及血清抗磷脂酶A2受体分布与老年IMN患者相似。青少年IMN患者对免疫抑制治疗反应良好。低剂量环孢素A作为维持治疗在缓解后有效,且不会增加肾毒性风险。